DMT Blood Monitoring! Are you safe?

By Lynda Kearney, MS Nurse , Victoria Hospital

More MS Academy Medication Projects

How Frequently Should Immunoglobulin Levels be Monitored in Patients with Multiple Sclerosis receiving Ocrelizumab?
By Dr Trisha Mukherjee, Neurology Specialist Registrar ST5, University College London Hospitals NHS Foundation Trust & Dr Cyrus Daruwalla, Neurology Specialist Registrar, Cambridge University Hospitals NHS Foundation Trust
Initiating a new Disease Modifying Treatment (DMT) into an existing service
By Sarah Hughes, Multiple Sclerosis Specialist Nurse, Torbay and South Devon NHS Foundation Trust
Reducing Delays to DMT Initiation via Homecare Prescriptions in Multiple Sclerosis
By Rebecca Harrison, Specialist Pharmacist for Neurology & Stroke Band 8, Royal United Hospitals Bath NHS Foundation Trust
Encouraging excellence, developing leaders, inspiring change

MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.